ESSA Pharma Inc (EPIX)
6.08
-0.04
(-0.65%)
USD |
NASDAQ |
Apr 26, 16:00
5.90
-0.18
(-2.96%)
After-Hours: 20:00
ESSA Pharma Enterprise Value: 126.85M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 126.85M |
| April 25, 2024 | 128.62M |
| April 24, 2024 | 134.37M |
| April 23, 2024 | 141.00M |
| April 22, 2024 | 141.00M |
| April 19, 2024 | 137.46M |
| April 18, 2024 | 155.16M |
| April 17, 2024 | 170.64M |
| April 16, 2024 | 186.57M |
| April 15, 2024 | 180.82M |
| April 12, 2024 | 201.17M |
| April 11, 2024 | 222.84M |
| April 10, 2024 | 204.71M |
| April 09, 2024 | 199.84M |
| April 08, 2024 | 226.38M |
| April 05, 2024 | 228.60M |
| April 04, 2024 | 218.86M |
| April 03, 2024 | 211.78M |
| April 02, 2024 | 220.63M |
| April 01, 2024 | 230.36M |
| March 28, 2024 | 233.46M |
| March 27, 2024 | 236.56M |
| March 26, 2024 | 249.39M |
| March 25, 2024 | 257.79M |
| March 22, 2024 | 257.35M |
| Date | Value |
|---|---|
| March 21, 2024 | 264.43M |
| March 20, 2024 | 264.87M |
| March 19, 2024 | 269.29M |
| March 18, 2024 | 260.45M |
| March 15, 2024 | 256.02M |
| March 14, 2024 | 251.60M |
| March 13, 2024 | 257.79M |
| March 12, 2024 | 252.93M |
| March 11, 2024 | 256.47M |
| March 08, 2024 | 265.31M |
| March 07, 2024 | 243.64M |
| March 06, 2024 | 243.64M |
| March 05, 2024 | 261.33M |
| March 04, 2024 | 262.66M |
| March 01, 2024 | 276.82M |
| February 29, 2024 | 278.14M |
| February 28, 2024 | 247.18M |
| February 27, 2024 | 236.12M |
| February 26, 2024 | 213.55M |
| February 23, 2024 | 206.48M |
| February 22, 2024 | 222.40M |
| February 21, 2024 | 220.63M |
| February 20, 2024 | 241.87M |
| February 16, 2024 | 262.66M |
| February 15, 2024 | 298.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-101.13M
Minimum
Oct 11 2022
1.187B
Maximum
Mar 12 2021
172.63M
Average
68.80M
Median
Apr 29 2022
Enterprise Value Benchmarks
| Acasti Pharma Inc | 2.144M |
| Aurinia Pharmaceuticals Inc | 359.58M |
| Edesa Biotech Inc | 9.751M |
| Lexaria Bioscience Corp | 25.12M |
| Xenon Pharmaceuticals Inc | 2.417B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.964M |
| Total Expenses (Quarterly) | 7.595M |
| EPS Diluted (Quarterly) | -0.14 |
| Earnings Yield | -9.70% |